vs
Pediatrix Medical Group, Inc.（MD）とSPORTSMAN'S WAREHOUSE HOLDINGS, INC.（SPWH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $331.3M、SPORTSMAN'S WAREHOUSE HOLDINGS, INC.の約1.5倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 0.0%、差は6.8%）。SPORTSMAN'S WAREHOUSE HOLDINGS, INC.の前年同期比売上増加率が高い（2.2% vs -1.7%）。過去8四半期でPediatrix Medical Group, Inc.の売上複合成長率が高い（-0.1% vs -5.4%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
Sportsman's Warehouseはアメリカ合衆国のアウトドアスポーツ用品小売業者で、全米29州に店舗を展開しています。狩猟、射撃、キャンプ、釣りなど各種アウトドアレクリエーション愛好家向けに、ウェア、シューズ、専門用品を販売しています。
MD vs SPWH — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $331.3M |
| 純利益 | $33.7M | $8.0K |
| 粗利率 | — | 32.8% |
| 営業利益率 | 9.9% | 1.3% |
| 純利益率 | 6.8% | 0.0% |
| 売上前年比 | -1.7% | 2.2% |
| 純利益前年比 | 10.5% | -97.8% |
| EPS（希薄化後） | $0.40 | $0.00 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $331.3M | ||
| Q3 25 | $492.9M | $293.9M | ||
| Q2 25 | $468.8M | $249.1M | ||
| Q1 25 | $458.4M | $340.4M | ||
| Q4 24 | $502.4M | $324.3M | ||
| Q3 24 | $511.2M | $288.7M | ||
| Q2 24 | $504.3M | $244.2M | ||
| Q1 24 | $495.1M | $370.4M |
| Q4 25 | $33.7M | $8.0K | ||
| Q3 25 | $71.7M | $-7.1M | ||
| Q2 25 | $39.3M | $-21.3M | ||
| Q1 25 | $20.7M | $-8.7M | ||
| Q4 24 | $30.5M | $-364.0K | ||
| Q3 24 | $19.4M | $-5.9M | ||
| Q2 24 | $-153.0M | $-18.1M | ||
| Q1 24 | $4.0M | $-8.7M |
| Q4 25 | — | 32.8% | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 30.4% | ||
| Q4 24 | — | 31.8% | ||
| Q3 24 | — | 31.2% | ||
| Q2 24 | — | 30.2% | ||
| Q1 24 | — | 26.8% |
| Q4 25 | 9.9% | 1.3% | ||
| Q3 25 | 13.8% | -1.1% | ||
| Q2 25 | 12.8% | -7.9% | ||
| Q1 25 | 7.0% | 1.1% | ||
| Q4 24 | 7.8% | 1.0% | ||
| Q3 24 | 6.6% | -1.5% | ||
| Q2 24 | -31.3% | -8.4% | ||
| Q1 24 | 3.2% | -2.1% |
| Q4 25 | 6.8% | 0.0% | ||
| Q3 25 | 14.5% | -2.4% | ||
| Q2 25 | 8.4% | -8.5% | ||
| Q1 25 | 4.5% | -2.6% | ||
| Q4 24 | 6.1% | -0.1% | ||
| Q3 24 | 3.8% | -2.0% | ||
| Q2 24 | -30.3% | -7.4% | ||
| Q1 24 | 0.8% | -2.4% |
| Q4 25 | $0.40 | $0.00 | ||
| Q3 25 | $0.84 | $-0.18 | ||
| Q2 25 | $0.46 | $-0.56 | ||
| Q1 25 | $0.24 | $-0.22 | ||
| Q4 24 | $0.37 | $-0.01 | ||
| Q3 24 | $0.23 | $-0.16 | ||
| Q2 24 | $-1.84 | $-0.48 | ||
| Q1 24 | $0.05 | $-0.22 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $2.2M |
| 総負債低いほど良い | $570.5M | $44.0M |
| 株主資本純資産 | $865.9M | $209.5M |
| 総資産 | $2.2B | $913.9M |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | 0.21× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $2.2M | ||
| Q3 25 | $340.1M | $1.8M | ||
| Q2 25 | $224.7M | $3.6M | ||
| Q1 25 | $99.0M | $2.8M | ||
| Q4 24 | $229.9M | $2.7M | ||
| Q3 24 | $103.8M | $2.6M | ||
| Q2 24 | $19.4M | $2.2M | ||
| Q1 24 | $8.0M | $3.1M |
| Q4 25 | $570.5M | $44.0M | ||
| Q3 25 | $577.2M | $43.9M | ||
| Q2 25 | $583.9M | $24.1M | ||
| Q1 25 | $590.5M | $24.1M | ||
| Q4 24 | $597.1M | $24.0M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $209.5M | ||
| Q3 25 | $890.7M | $208.9M | ||
| Q2 25 | $833.8M | $215.1M | ||
| Q1 25 | $789.2M | $235.7M | ||
| Q4 24 | $764.9M | $243.6M | ||
| Q3 24 | $732.5M | $243.0M | ||
| Q2 24 | $706.5M | $247.5M | ||
| Q1 24 | $856.2M | $264.6M |
| Q4 25 | $2.2B | $913.9M | ||
| Q3 25 | $2.2B | $948.9M | ||
| Q2 25 | $2.1B | $929.7M | ||
| Q1 25 | $2.0B | $852.1M | ||
| Q4 24 | $2.2B | $967.7M | ||
| Q3 24 | $2.1B | $901.9M | ||
| Q2 24 | $2.0B | $930.4M | ||
| Q1 24 | $2.2B | $886.2M |
| Q4 25 | 0.66× | 0.21× | ||
| Q3 25 | 0.65× | 0.21× | ||
| Q2 25 | 0.70× | 0.11× | ||
| Q1 25 | 0.75× | 0.10× | ||
| Q4 24 | 0.78× | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $16.3M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $8.7M |
| FCFマージンFCF / 売上 | — | 2.6% |
| 設備投資強度設備投資 / 売上 | — | 2.3% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 2038.00× |
| 直近12ヶ月FCF直近4四半期 | — | $-39.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $16.3M | ||
| Q3 25 | $137.3M | $-26.6M | ||
| Q2 25 | $137.2M | $-60.2M | ||
| Q1 25 | $-117.5M | $52.8M | ||
| Q4 24 | $133.0M | $-2.5M | ||
| Q3 24 | $91.8M | $18.5M | ||
| Q2 24 | $107.0M | $-34.6M | ||
| Q1 24 | $-125.2M | $68.9M |
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $-33.9M | ||
| Q2 25 | — | $-64.0M | ||
| Q1 25 | — | $49.6M | ||
| Q4 24 | — | $-6.2M | ||
| Q3 24 | — | $14.1M | ||
| Q2 24 | — | $-38.0M | ||
| Q1 24 | — | $60.2M |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | -11.5% | ||
| Q2 25 | — | -25.7% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | -1.9% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | -15.5% | ||
| Q1 24 | — | 16.2% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | 3.39× | 2038.00× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SPWH
セグメントデータなし
